Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Supplementary Figure S2: Efficacy outcomes with adagrasib monotherapy in previously treated patients with KRASG12C-mutated unresecable or metastatic CRC.